Workflow
AXON ANNOUNCES PRICING OF UPSIZED OFFERING OF $1,000.0 MILLION OF 6.125% SENIOR NOTES DUE 2030 AND $750.0 MILLION OF 6.250% SENIOR NOTES DUE 2033
AxonAxon(US:AXON) Prnewswireยท2025-03-05 21:20

Core Viewpoint - Axon has successfully priced a total of $1,750.0 million in Senior Notes, with the proceeds intended for general corporate purposes, including potential repurchases of existing convertible notes and funding growth initiatives [1][3]. Group 1: Offering Details - Axon priced $1,000.0 million of Senior Notes due 2030 and $750.0 million of Senior Notes due 2033, both at an issue price of 100% [1]. - The total offering size was increased from a previously announced $1,500.0 million [1]. - The sale of the Notes is expected to close on March 11, 2025, subject to customary closing conditions [1]. Group 2: Interest Rates and Maturity - The 2030 Notes will have an interest rate of 6.125% per year, payable semiannually starting September 15, 2025, and maturing on March 15, 2030 [3]. - The 2033 Notes will bear an interest rate of 6.250% per year, also payable semiannually starting September 15, 2025, and maturing on March 15, 2033 [3]. Group 3: Use of Proceeds - The net proceeds from the offering will be used for general corporate purposes, which may include repurchasing or redeeming existing convertible notes and supporting growth through acquisitions or investments in new products and technologies [1]. Group 4: Notes Characteristics - The Notes will be general senior unsecured obligations of Axon, with no guarantees from its subsidiaries at the issue date [2]. - Future domestic securities that guarantee Axon's existing revolving credit facility will guarantee the Notes, subject to certain exceptions [2]. Group 5: Company Overview - Axon is a technology leader in global public safety, aiming to reduce gun-related deaths by 50% before 2033 [6]. - The company integrates hardware devices and cloud software solutions to modernize policing, serving a diverse customer base including law enforcement and emergency services [6].